Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response

Journal of Molecular Biology

Volumn 427, Issue 23, 2015, Pages 3628-3645

  Rybtke, Morten ^a   Hultqvist, Louise Dahl ^a   Givskov, Michael ^a,b   Tolker Nielsen, Tim ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Abbreviations CF cystic fibrosis; COM chronic otitis media; eDNA extracellular DNA; NET neutrophil extracellular trap; PMN polymorphonuclear leukocyte; QS quorum sensing; ROS reactive oxygen species; RSCV rugose small colony variants

Indexed keywords

ARTIFICIAL HEART PACEMAKER; BIOFILM; CHRONIC OTITIS MEDIA; CHRONIC PROSTATITIS; CHRONIC WOUND; COMMUNITY STRUCTURE; CYSTIC FIBROSIS; DEVICE INFECTION; EXTRACELLULAR MATRIX; HEART VALVE PROSTHESIS; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMPLANT; IN VITRO STUDY; INDWELLING CATHETER; INTRAVENOUS CATHETER; JOINT PROSTHESIS; NONHUMAN; PERITONEAL DIALYSIS CATHETER; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW; WOUND INFECTION; ANIMAL; CHEMISTRY; CHRONIC DISEASE; DRUG EFFECTS; FOREIGN BODY; IMMUNOLOGY; MALE; MICROBIOLOGY; OTITIS MEDIA; PATHOGENICITY; PHYSIOLOGY; PROSTATITIS; PSEUDOMONAS INFECTIONS;

ANTIINFECTIVE AGENT;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CHRONIC DISEASE; CYSTIC FIBROSIS; EXTRACELLULAR MATRIX; FOREIGN BODIES; HUMANS; IMMUNE EVASION; MALE; OTITIS MEDIA; PROSTATITIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; WOUND INFECTION;

EID: 84946060593     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2015.08.016     Document Type: Review

References (238)

1. J.W. Costerton, P.S. Stewart, and E.P. Greenberg Bacterial biofilms: A common cause of persistent infections Science 284 1999 1318 1322
2. O. Ciofu, T. Tolker-Nielsen, P.O. Jensen, H. Wang, and N. Hoiby Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients Adv. Drug Deliv. Rev. 85 2015 7 23
3. A. Bauernfeind, R.M. Bertele, K. Harms, G. Horl, R. Jungwirth, C. Petermuller, and et al. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis Infection 15 1987 270 277
4. L. Saiman Microbiology of early CF lung disease Paediatr. Respir. Rev. 5 2004 S367 S369
5. P.H. Gilligan Microbiology of airway disease in patients with cystic fibrosis Clin. Microbiol. Rev. 4 1991 35 51
6. C. Koch, and N. Hoiby Pathogenesis of cystic fibrosis Lancet 341 1993 1065 1069
7. D.N. Collier, L. Anderson, S.L. McKnight, T.L. Noah, M. Knowles, R. Boucher, and et al. A bacterial cell to cell signal in the lungs of cystic fibrosis patients FEMS Microbiol. Lett. 215 2002 41 46
8. C. Koch Early infection and progression of cystic fibrosis lung disease Pediatr. Pulmonol. 34 2002 232 236
9. G. Doring, N. Høiby, and G. Consensus Study Early intervention and prevention of lung disease in cystic fibrosis: A European consensus J. Cyst. Fibros. 3 2004 67 91
10. J.B. Lyczak, C.L. Cannon, and G.B. Pier Lung infections associated with cystic fibrosis Clin. Microbiol. Rev. 15 2002 194 222
11. N. Hoiby, O. Ciofu, and T. Bjarnsholt Pseudomonas aeruginosa biofilms in cystic fibrosis Future Microbiol 5 2010 1663 1674
12. T.S. Cohen, and A. Prince Cystic fibrosis: A mucosal immunodeficiency syndrome Nat. Med. 18 2012 509 519
13. Cystic Fibrosis Foundation, Bethesda, MD Cystic Fibrosis Foundation Patient Registry 2004 annual data report to the center directors Annual report of the Cystic Fibrosis Foundation that provides basic epidemiologic data on the cystic fibrosis population in the United States 2005
14. M. Hofer, C. Benden, I. Inci, C. Schmid, S. Irani, R. Speich, and et al. True survival benefit of lung transplantation for cystic fibrosis patients: The Zurich experience J. Heart Lung Transplant. 28 2009 334 339
15. N. Høiby Pseudomonas aeruginosa infection in cystic fibrosis (dissertation) 1977 University of Copenhagen
16. J. Lam, R. Chan, K. Lam, and J.W. Costerton Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis Infect. Immun. 28 1980 546 556
17. R.S. Baltimore, C.D. Christie, and G.J. Smith Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration Am. Rev. Respir. Dis. 140 1989 1650 1661
18. R.L. Gibson, J.L. Burns, and B.W. Ramsey Pathophysiology and management of pulmonary infections in cystic fibrosis Am. J. Respir. Crit. Care Med. 168 2003 918 951
19. P.O. Jensen, T. Bjarnsholt, R. Phipps, T.B. Rasmussen, H. Calum, L. Christoffersen, and et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa Microbiology 153 2007 1329 1338
20. T.R. Shryock, S.A. Silver, M.W. Banschbach, and J.C. Kramer Effect of Pseudomonas aeruginosa rhamnolipid on human neutrophil migration Curr. Microbiol. 10 1984 323 328
21. R.C. Boucher An overview of the pathogenesis of cystic fibrosis lung disease Adv. Drug Deliv. Rev. 54 2002 1359 1371
22. S.H. Donaldson, and R.C. Boucher Update on pathogenesis of cystic fibrosis lung disease Curr. Opin. Pulm. Med. 9 2003 486 491
23. P.O. Jensen, M. Givskov, T. Bjarnsholt, and C. Moser The immune system vs. Pseudomonas aeruginosa biofilms FEMS Immunol. Med. Microbiol. 59 2010 292 305
24. T. Bjarnsholt, P.O. Jensen, M.J. Fiandaca, J. Pedersen, C.R. Hansen, C.B. Andersen, and et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients Pediatr. Pulmonol. 44 2009 547 558
25. T. Mustoe Understanding chronic wounds: A unifying hypothesis on their pathogenesis and implications for therapy Am. J. Surg. 187 2004 65S 70S
26. K. Gjødsbøl, J.J. Christensen, T. Karlsmark, B. Jorgensen, B.M. Klein, and K.A. Krogfelt Multiple bacterial species reside in chronic wounds: A longitudinal study Int. Wound J. 3 2006 225 231
27. K. Kirketerp-Moller, P.O. Jensen, M. Fazli, K.G. Madsen, J. Pedersen, C. Moser, and et al. Distribution, organization, and ecology of bacteria in chronic wounds J. Clin. Microbiol. 46 2008 2717 2722
28. M. Fazli, T. Bjarnsholt, K. Kirketerp-Moller, B. Jorgensen, A.S. Andersen, K.A. Krogfelt, and et al. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds J. Clin. Microbiol. 47 2009 4084 4089
29. M. Fazli, T. Bjarnsholt, K. Kirketerp-Moller, A. Jorgensen, C.B. Andersen, M. Givskov, and et al. Quantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic wounds Wound Repair Regen. 19 2011 387 391
30. T. Bjarnsholt, K. Kirketerp-Moller, P.O. Jensen, K.G. Madsen, R. Phipps, K. Krogfelt, and et al. Why chronic wounds will not heal: A novel hypothesis Wound Repair Regen. 16 2008 2 10
31. A.R. Halbert, M.C. Stacey, J.B. Rohr, and A. Jopp-McKay The effect of bacterial colonization on venous ulcer healing Australas. J. Dermatol. 33 1992 75 80
32. S.M. Madsen, H. Westh, L. Danielsen, and V.T. Rosdahl Bacterial colonization and healing of venous leg ulcers APMIS 104 1996 895 899
33. M.S. Agren, W.H. Eaglstein, M.W. Ferguson, K.G. Harding, K. Moore, U.K. Saarialho-Kere, and et al. Causes and effects of the chronic inflammation in venous leg ulcers Acta Derm. Venereol. Suppl. 210 2000 3 17
34. E.A. Grice, and J.A. Segre Interaction of the microbiome with the innate immune response in chronic wounds Adv. Exp. Med. Biol. 946 2012 55 68
35. G.S. Schultz, R.G. Sibbald, V. Falanga, E.A. Ayello, C. Dowsett, K. Harding, and et al. Wound bed preparation: A systematic approach to wound management Wound Repair Regen. 11 2003 S1 S28
36. D.R. Yager, and B.C. Nwomeh The proteolytic environment of chronic wounds Wound Repair Regen. 7 1999 433 441
37. T.R. Coker, L.S. Chan, S.J. Newberry, M.A. Limbos, M.J. Suttorp, P.G. Shekelle, and et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: A systematic review JAMA 304 2010 2161 2169
38. K.E. Bennett, M.P. Haggard, P.A. Silva, and I.A. Stewart Behaviour and developmental effects of otitis media with effusion into the teens Arch. Dis. Child. 85 2001 91 95
39. L. Hall-Stoodley, F.Z. Hu, A. Gieseke, L. Nistico, D. Nguyen, J. Hayes, and et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media JAMA 296 2006 202 211
40. T. Bjarnsholt The role of bacterial biofilms in chronic infections APMIS Suppl. 2013 1 51 10.1111/apm.12099
41. G.D. Ehrlich, R. Veeh, X. Wang, J.W. Costerton, J.D. Hayes, F.Z. Hu, and et al. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media JAMA 287 2002 1710 1715
42. M.G. Rayner, Y. Zhang, M.C. Gorry, Y. Chen, J.C. Post, and G.D. Ehrlich Evidence of bacterial metabolic activity in culture-negative otitis media with effusion JAMA 279 1998 296 299
43. P. Homøe, T. Bjarnsholt, M. Wessman, H.C. Sorensen, and H.K. Johansen Morphological evidence of biofilm formation in Greenlanders with chronic suppurative otitis media Eur. Arch. Otorhinolaryngol. 266 2009 1533 1538
44. M. Wessman, T. Bjarnsholt, S.R. Eickhardt-Sorensen, H.K. Johansen, and P. Homoe Mucosal biofilm detection in chronic otitis media: A study of middle ear biopsies from Greenlandic patients Eur. Arch. Otorhinolaryngol. 272 2015 1079 1085
45. M.R. Lee, K.S. Pawlowski, A. Luong, A.D. Furze, and P.S. Roland Biofilm presence in humans with chronic suppurative otitis media Otolaryngol. Head Neck Surg. 141 2009 567 571
46. L.O. Bakaletz Bacterial biofilms in otitis media: Evidence and relevance Pediatr. Infect. Dis. J. 26 2007 S17 S19
47. M.R. Bothwell, A.L. Smith, and T. Phillips Recalcitrant otorrhea due to Pseudomonas biofilm Otolaryngol. Head Neck Surg. 129 2003 599 601
48. M. Burmolle, T.R. Thomsen, M. Fazli, I. Dige, L. Christensen, P. Homoe, and et al. Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections FEMS Immunol. Med. Microbiol. 59 2010 324 336
49. M. Hoa, S. Tomovic, L. Nistico, L. Hall-Stoodley, P. Stoodley, L. Sachdeva, and et al. Identification of adenoid biofilms with middle ear pathogens in otitis-prone children utilizing SEM and FISH Int. J. Pediatr. Otorhinolaryngol. 73 2009 1242 1248
50. J.C. Nickel, J. Downey, D. Hunter, and J. Clark Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index J. Urol. 165 2001 842 845
51. A. Mehik, P. Hellstrom, O. Lukkarinen, A. Sarpola, and M. Jarvelin Epidemiology of prostatitis in Finnish men: A population-based cross-sectional study BJU Int. 86 2000 443 448
52. J.C. Nickel, and J.W. Costerton Bacterial localization in antibiotic-refractory chronic bacterial prostatitis Prostate 23 1993 107 114
53. J.C. Nickel, M.E. Olson, A. Barabas, H. Benediktsson, M.K. Dasgupta, and J.W. Costerton Pathogenesis of chronic bacterial prostatitis in an animal model Br. J. Urol. 66 1990 47 54
54. A.G. Gristina Biomaterial-centered infection: Microbial adhesion versus tissue integration Science 237 1987 1588 1595
55. J.W. Costerton, L. Montanaro, and C.R. Arciola Biofilm in implant infections: Its production and regulation Int. J. Artif. Organs 28 2005 1062 1068
56. E.E. Braxton Jr., G.D. Ehrlich, L. Hall-Stoodley, P. Stoodley, R. Veeh, C. Fux, and et al. Role of biofilms in neurosurgical device-related infections Neurosurg. Rev. 28 2005 249 255
57. F.A. Waldvogel, and A.L. Bisno Infections Associated With Indwelling Medical Devices 2000 ASM Press
58. A. Trampuz, and W. Zimmerli Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment Drugs 66 2006 1089 1105
59. R.M. Donlan, and J.W. Costerton Biofilms: Survival mechanisms of clinically relevant microorganisms Clin. Microbiol. Rev. 15 2002 167 193
60. K. Lewis Persister cells, dormancy and infectious disease Nat. Rev. Microbiol. 5 2007 48 56
61. K. Lewis Riddle of biofilm resistance Antimicrob. Agents Chemother. 45 2001 999 1007
62. J. Goldstone, and W.S. Moore Infection in vascular prostheses. Clinical manifestations and surgical management Am. J. Surg. 128 1974 225 233
63. S.H. Dougherty Pathobiology of infection in prosthetic devices Rev. Infect. Dis. 10 1988 1102 1117
64. C. Lassek, M. Burghartz, D. Chaves-Moreno, A. Otto, C. Hentschker, S. Fuchs, and et al. A metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections CAUTIs Mol. Cell. Proteomics 14 2015 989 1008
65. C. Moser, N.J. Kriegbaum, S.O. Larsen, N. Hoiby, and F. Biering-Sorensen Antibodies to urinary tract pathogens in patients with spinal cord lesions Spinal Cord 36 1998 613 616
66. N. Hoiby, O. Ciofu, H.K. Johansen, Z.J. Song, C. Moser, P.O. Jensen, and et al. The clinical impact of bacterial biofilms Int. J. Oral Sci. 3 2011 55 65
67. H.A. Cash, D.E. Woods, B. McCullough, W.G. Johanson Jr., and J.A. Bass A rat model of chronic respiratory infection with Pseudomonas aeruginosa Am. Rev. Respir. Dis. 119 1979 453 459
68. S.S. Pedersen, G.H. Shand, B.L. Hansen, and G.N. Hansen Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres APMIS 98 1990 203 211
69. C. Moser, H.K. Johansen, Z. Song, H.P. Hougen, J. Rygaard, and N. Hoiby Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice APMIS 105 1997 838 842
70. T.H. Jakobsen, M. van Gennip, R.K. Phipps, M.S. Shanmugham, L.D. Christensen, M. Alhede, and et al. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing Antimicrob. Agents Chemother. 56 2012 2314 2325
71. T. Bjarnsholt, P.O. Jensen, T.B. Rasmussen, L. Christophersen, H. Calum, M. Hentzer, and et al. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections Microbiology 151 2005 3873 3880
72. H. Wu, Z. Song, M. Hentzer, J.B. Andersen, S. Molin, M. Givskov, and et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice J. Antimicrob. Chemother. 53 2004 1054 1061
73. C. Moser, S. Kjaergaard, T. Pressler, A. Kharazmi, C. Koch, and N. Hoiby The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type APMIS 108 2000 329 335
74. C. Moser, M. Van Gennip, T. Bjarnsholt, P.O. Jensen, B. Lee, H.P. Hougen, and et al. Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis APMIS 117 2009 95 107
75. W. Hengzhuang, H. Wu, O. Ciofu, Z. Song, and N. Hoiby Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms Antimicrob. Agents Chemother. 55 2011 4469 4474
76. T. Bjarnsholt, P.O. Jensen, M. Burmolle, M. Hentzer, J.A. Haagensen, H.P. Hougen, and et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent Microbiology 151 2005 373 383
77. M. Van Gennip, L.D. Christensen, M. Alhede, R. Phipps, P.O. Jensen, L. Christophersen, and et al. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes APMIS 117 2009 537 546
78. M. van Gennip, C. Moser, L.D. Christensen, T. Bjarnsholt, H. Calum, P.O. Jensen, and et al. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa J. Antimicrob. Chemother. 64 2009 1241 1250
79. M. Hentzer, H. Wu, J.B. Andersen, K. Riedel, T.B. Rasmussen, N. Bagge, and et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors EMBO J. 22 2003 3803 3815
80. L. Yang, W. Hengzhuang, H. Wu, S. Damkiaer, N. Jochumsen, Z. Song, and et al. Polysaccharides serve as scaffold of biofilms formed by mucoid Pseudomonas aeruginosa FEMS Immunol. Med. Microbiol. 65 2012 366 376
81. G. Zhao, P.C. Hochwalt, M.L. Usui, R.A. Underwood, P.K. Singh, G.A. James, and et al. Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: A model for the study of chronic wounds Wound Repair Regen. 18 2010 467 477
82. H. Trøstrup, K. Thomsen, L.J. Christophersen, H.P. Hougen, T. Bjarnsholt, P.O. Jensen, and et al. Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model Wound Repair Regen. 21 2013 292 299
83. K. Kirketerp-Moller, and F. Gottrup Bacterial biofilm in chronic wounds Ugeskr. Laeger 171 2009 1097
84. M.S. Byrd, B. Pang, W. Hong, E.A. Waligora, R.A. Juneau, C.E. Armbruster, and et al. Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model Infect. Immun. 79 2011 3087 3095
85. E.J. Chaney, C.T. Nguyen, and S.A. Boppart Novel method for non-invasive induction of a middle-ear biofilm in the rat Vaccine 29 2011 1628 1633
86. J.E. Dohar, P.A. Hebda, R. Veeh, M. Awad, J.W. Costerton, J. Hayes, and et al. Mucosal biofilm formation on middle-ear mucosa in a nonhuman primate model of chronic suppurative otitis media Laryngoscope 115 2005 1469 1472
87. J. Jurcisek, L. Greiner, H. Watanabe, A. Zaleski, M.A. Apicella, and L.O. Bakaletz Role of sialic acid and complex carbohydrate biosynthesis in biofilm formation by nontypeable Haemophilus influenzae in the chinchilla middle ear Infect. Immun. 73 2005 3210 3218
88. W.E. Swords, M.L. Moore, L. Godzicki, G. Bukofzer, M.J. Mitten, and J. VonCannon Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae Infect. Immun. 72 2004 106 113
89. J.C. Post Direct evidence of bacterial biofilms in otitis media Laryngoscope 111 2001 2083 2094
90. U. Komor, P. Bielecki, H. Loessner, M. Rohde, K. Wolf, K. Westphal, and et al. Biofilm formation by Pseudomonas aeruginosa in solid murine tumors - A novel model system Microbes Infect. 14 2012 951 958
91. V. Pawar, K. Crull, U. Komor, N. Kasnitz, M. Frahm, D. Kocijancic, and et al. Murine solid tumours as a novel model to study bacterial biofilm formation in vivo J. Intern. Med. 276 2014 130 139
92. V. Pawar, U. Komor, N. Kasnitz, P. Bielecki, M.C. Pils, B. Gocht, and et al. In vivo efficacy of antimicrobials against biofilm-producing Pseudomonas aeruginosa Antimicrob. Agents Chemother. 59 2015 4974 4981
93. M. Allesen-Holm, K.B. Barken, L. Yang, M. Klausen, J.S. Webb, S. Kjelleberg, and et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms Mol. Microbiol. 59 2006 1114 1128
94. L. Yang, M. Nilsson, M. Gjermansen, M. Givskov, and T. Tolker-Nielsen Pyoverdine and PQS mediated subpopulation interactions involved in Pseudomonas aeruginosa biofilm formation Mol. Microbiol. 74 2009 1380 1392
95. P. Bielecki, U. Komor, A. Bielecka, M. Musken, J. Puchalka, M.W. Pletz, and et al. Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites Environ. Microbiol. 15 2013 570 587
96. A. Buret, K.H. Ward, M.E. Olson, and J.W. Costerton An in vivo model to study the pathobiology of infectious biofilms on biomaterial surfaces J. Biomed. Mater. Res. 25 1991 865 874
97. L.D. Christensen, C. Moser, P.O. Jensen, T.B. Rasmussen, L. Christophersen, S. Kjelleberg, and et al. Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence in an in vivo intraperitoneal foreign-body infection model Microbiology 153 2007 2312 2320
98. L.D. Christensen, M. van Gennip, T.H. Jakobsen, M. Alhede, H.P. Hougen, N. Hoiby, and et al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model J. Antimicrob. Chemother. 67 2012 1198 1206
99. M. van Gennip, L.D. Christensen, M. Alhede, K. Qvortrup, P.O. Jensen, N. Hoiby, and et al. Interactions between polymorphonuclear leukocytes and Pseudomonas aeruginosa biofilms on silicone implants in vivo Infect. Immun. 80 2012 260 267
100. L.D. Christensen, M. van Gennip, M.T. Rybtke, H. Wu, W.C. Chiang, M. Alhede, and et al. Clearance of Pseudomonas aeruginosa foreign-body biofilm infections through reduction of the cyclic Di-GMP level in the bacteria Infect. Immun. 81 2013 2705 2713
101. W.C. Chiang, M. Nilsson, P.O. Jensen, N. Hoiby, T.E. Nielsen, M. Givskov, and et al. Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms Antimicrob. Agents Chemother. 57 2013 2352 2361
102. T.H. Jakobsen, S.K. Bragason, R.K. Phipps, L.D. Christensen, M. van Gennip, M. Alhede, and et al. Food as a source for quorum sensing inhibitors: Iberin from horseradish revealed as a quorum sensing inhibitor of Pseudomonas aeruginosa Appl. Environ. Microbiol. 78 2012 2410 2421
103. O. Cirioni, R. Ghiselli, C. Silvestri, D. Minardi, E. Gabrielli, F. Orlando, and et al. Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection J. Antimicrob. Chemother. 66 2011 1318 1323
104. M. Klausen, A. Heydorn, P. Ragas, L. Lambertsen, A. Aaes-Jorgensen, S. Molin, and et al. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants Mol. Microbiol. 48 2003 1511 1524
105. M. Klausen, A. Aaes-Jorgensen, S. Molin, and T. Tolker-Nielsen Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms Mol. Microbiol. 50 2003 61 68
106. M. Harmsen, L. Yang, S.J. Pamp, and T. Tolker-Nielsen An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal FEMS Immunol. Med. Microbiol. 59 2010 253 268
107. B. Purevdorj-Gage, W.J. Costerton, and P. Stoodley Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms Microbiology 151 2005 1569 1576
108. D.J. Wozniak, T.J. Wyckoff, M. Starkey, R. Keyser, P. Azadi, G.A. O'Toole, and et al. Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms Proc. Natl. Acad. Sci. U. S. A. 100 2003 7907 7912
109. J.R. Govan, and V. Deretic Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia Microbiol. Rev. 60 1996 539 574
110. K. Mathee, O. Ciofu, C. Sternberg, P.W. Lindum, J.I. Campbell, P. Jensen, and et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: A mechanism for virulence activation in the cystic fibrosis lung Microbiology 145 1999 1349 1357
111. J.C. Boucher, H. Yu, M.H. Mudd, and V. Deretic Mucoid Pseudomonas aeruginosa in cystic fibrosis: Characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection Infect. Immun. 65 1997 3838 3846
112. L. Ma, H. Lu, A. Sprinkle, M.R. Parsek, and D.J. Wozniak Pseudomonas aeruginosa Psl is a galactose- and mannose-rich exopolysaccharide J. Bacteriol. 189 2007 8353 8356
113. M.S. Byrd, I. Sadovskaya, E. Vinogradov, H. Lu, A.B. Sprinkle, S.H. Richardson, and et al. Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production Mol. Microbiol. 73 2009 622 638
114. L. Ma, K.D. Jackson, R.M. Landry, M.R. Parsek, and D.J. Wozniak Analysis of Pseudomonas aeruginosa conditional Psl variants reveals roles for the Psl polysaccharide in adhesion and maintaining biofilm structure postattachment J. Bacteriol. 188 2006 8213 8221
115. A. Ghafoor, I.D. Hay, and B.H. Rehm Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture Appl. Environ. Microbiol. 77 2011 5238 5246
116. L. Ma, M. Conover, H. Lu, M.R. Parsek, K. Bayles, and D.J. Wozniak Assembly and development of the Pseudomonas aeruginosa biofilm matrix PLoS Pathog. 5 2009 e1000354
117. B.R. Borlee, A.D. Goldman, K. Murakami, R. Samudrala, D.J. Wozniak, and M.R. Parsek Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix Mol. Microbiol. 75 2010 827 842
118. S. Wang, M.R. Parsek, D.J. Wozniak, and L.Z. Ma A spider web strategy of type IV pili-mediated migration to build a fibre-like Psl polysaccharide matrix in Pseudomonas aeruginosa biofilms Environ. Microbiol. 15 2013 2238 2253
119. K. Zhao, B.S. Tseng, B. Beckerman, F. Jin, M.L. Gibiansky, J.J. Harrison, and et al. Psl trails guide exploration and microcolony formation in Pseudomonas aeruginosa biofilms Nature 497 2013 388 391
120. L. Friedman, and R. Kolter Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix J. Bacteriol. 186 2004 4457 4465
121. K.M. Colvin, Y. Irie, C.S. Tart, R. Urbano, J.C. Whitney, C. Ryder, and et al. The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix Environ. Microbiol. 14 2012 1913 1928
122. P. Vasseur, I. Vallet-Gely, C. Soscia, S. Genin, and A. Filloux The pel genes of the Pseudomonas aeruginosa PAK strain are involved at early and late stages of biofilm formation Microbiology 151 2005 985 997
123. K.M. Colvin, V.D. Gordon, K. Murakami, B.R. Borlee, D.J. Wozniak, G.C. Wong, and et al. The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa PLoS Pathog. 7 2011 e1001264
124. L. Yang, Y. Hu, Y. Liu, J. Zhang, J. Ulstrup, and S. Molin Distinct roles of extracellular polymeric substances in Pseudomonas aeruginosa biofilm development Environ. Microbiol. 13 2011 1705 1717
125. S.C. Chew, B. Kundukad, T. Seviour, J.R. van der Maarel, L. Yang, S.A. Rice, and et al. Dynamic remodeling of microbial biofilms by functionally distinct exopolysaccharides MBio 5 2014 e01536-14
126. L. Ma, S. Wang, D. Wang, M.R. Parsek, and D.J. Wozniak The roles of biofilm matrix polysaccharide Psl in mucoid Pseudomonas aeruginosa biofilms FEMS Immunol. Med. Microbiol. 65 2012 377 380
127. I.D. Hay, K. Gatland, A. Campisano, J.Z. Jordens, and B.H. Rehm Impact of alginate overproduction on attachment and biofilm architecture of a supermucoid Pseudomonas aeruginosa strain Appl. Environ. Microbiol. 75 2009 6022 6025
128. M. Hentzer, G.M. Teitzel, G.J. Balzer, A. Heydorn, S. Molin, M. Givskov, and et al. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function J. Bacteriol. 183 2001 5395 5401
129. C.B. Whitchurch, T. Tolker-Nielsen, P.C. Ragas, and J.S. Mattick Extracellular DNA required for bacterial biofilm formation Science 295 2002 1487
130. T.S. Walker, K.L. Tomlin, G.S. Worthen, K.R. Poch, J.G. Lieber, M.T. Saavedra, and et al. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils Infect. Immun. 73 2005 3693 3701
131. Q.M. Parks, R.L. Young, K.R. Poch, K.C. Malcolm, M.L. Vasil, and J.A. Nick Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: Human F-actin and DNA as targets for therapy J. Med. Microbiol. 58 2009 492 502
132. S. Wang, X. Liu, H. Liu, L. Zhang, Y. Guo, S. Yu, and et al. The exopolysaccharide Psl-eDNA interaction enables the formation of a biofilm skeleton in Pseudomonas aeruginosa Environ. Microbiol. Rep. 7 2015 330 340
133. F.E. Aas, C. Lovold, and M. Koomey An inhibitor of DNA binding and uptake events dictates the proficiency of genetic transformation in Neisseria gonorrhoeae: Mechanism of action and links to type IV pilus expression Mol. Microbiol. 46 2002 1441 1450
134. E.J. van Schaik, C.L. Giltner, G.F. Audette, D.W. Keizer, D.L. Bautista, C.M. Slupsky, and et al. DNA binding: A novel function of Pseudomonas aeruginosa type IV pili J. Bacteriol. 187 2005 1455 1464
135. K.B. Barken, S.J. Pamp, L. Yang, M. Gjermansen, J.J. Bertrand, M. Klausen, and et al. Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms Environ. Microbiol. 10 2008 2331 2343
136. I. Vallet, J.W. Olson, S. Lory, A. Lazdunski, and A. Filloux The chaperone/usher pathways of Pseudomonas aeruginosa: Identification of fimbrial gene clusters (cup) and their involvement in biofilm formation Proc. Natl. Acad. Sci. U. S. A. 98 2001 6911 6916
137. H.D. Kulasekara, I. Ventre, B.R. Kulasekara, A. Lazdunski, A. Filloux, and S. Lory A novel two-component system controls the expression of Pseudomonas aeruginosa fimbrial cup genes Mol. Microbiol. 55 2005 368 380
138. H. Mikkelsen, G. Ball, C. Giraud, and A. Filloux Expression of Pseudomonas aeruginosa CupD fimbrial genes is antagonistically controlled by RcsB and the EAL-containing PvrR response regulators PLoS One 4 2009 e6018
139. D. Tielker, S. Hacker, R. Loris, M. Strathmann, J. Wingender, S. Wilhelm, and et al. Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation Microbiology 151 2005 1313 1323
140. M.S. Dueholm, M.T. Sondergaard, M. Nilsson, G. Christiansen, A. Stensballe, M.T. Overgaard, and et al. Expression of Fap amyloids in Pseudomonas aeruginosa, P. fluorescens, and P. putida results in aggregation and increased biofilm formation MicrobiologyOpen 2 2013 365 382
141. M. Fazli, H. Almblad, M.L. Rybtke, M. Givskov, L. Eberl, and T. Tolker-Nielsen Regulation of biofilm formation in Pseudomonas and Burkholderia species Environ. Microbiol. 16 2014 1961 1981
142. R. Hengge Principles of c-di-GMP signalling in bacteria Nat. Rev. Microbiol. 7 2009 263 273
143. J.P. Massie, E.L. Reynolds, B.J. Koestler, J.P. Cong, M. Agostoni, and C.M. Waters Quantification of high-specificity cyclic diguanylate signaling Proc. Natl. Acad. Sci. U. S. A. 109 2012 12746 12751
144. J.H. Merritt, K.M. Brothers, S.L. Kuchma, and G.A. O'Toole SadC reciprocally influences biofilm formation and swarming motility via modulation of exopolysaccharide production and flagellar function J. Bacteriol. 189 2007 8154 8164
145. V.T. Lee, J.M. Matewish, J.L. Kessler, M. Hyodo, Y. Hayakawa, and S. Lory A cyclic-di-GMP receptor required for bacterial exopolysaccharide production Mol. Microbiol. 65 2007 1474 1484
146. J.W. Hickman, and C.S. Harwood Identification of FleQ from Pseudomonas aeruginosa as a c-di-GMP-responsive transcription factor Mol. Microbiol. 69 2008 376 389
147. M. Merighi, V.T. Lee, M. Hyodo, Y. Hayakawa, and S. Lory The second messenger bis-(3′-5′)-cyclic-GMP and its PilZ domain-containing receptor Alg44 are required for alginate biosynthesis in Pseudomonas aeruginosa Mol. Microbiol. 65 2007 876 895
148. I.D. Hay, U. Remminghorst, and B.H. Rehm MucR, a novel membrane-associated regulator of alginate biosynthesis in Pseudomonas aeruginosa Appl. Environ. Microbiol. 75 2009 1110 1120
149. S.L. Kuchma, J.P. Connolly, and G.A. O'Toole A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa J. Bacteriol. 187 2005 1441 1454
150. M. Starkey, J.H. Hickman, L. Ma, N. Zhang, S. De Long, A. Hinz, and et al. Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung J. Bacteriol. 191 2009 3492 3503
151. J.G. Malone, T. Jaeger, C. Spangler, D. Ritz, A. Spang, C. Arrieumerlou, and et al. YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa PLoS Pathog. 6 2010 e1000804
152. Y. Li, S. Heine, M. Entian, K. Sauer, and N. Frankenberg-Dinkel NO-induced biofilm dispersion in Pseudomonas aeruginosa is mediated by an MHYT domain-coupled phosphodiesterase J. Bacteriol. 195 2013 3531 3542
153. S. An, J. Wu, and L.H. Zhang Modulation of Pseudomonas aeruginosa biofilm dispersal by a cyclic-Di-GMP phosphodiesterase with a putative hypoxia-sensing domain Appl. Environ. Microbiol. 76 2010 8160 8173
154. N. Barraud, D. Schleheck, J. Klebensberger, J.S. Webb, D.J. Hassett, S.A. Rice, and et al. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal J. Bacteriol. 191 2009 7333 7342
155. M. Juhas, L. Eberl, and B. Tummler Quorum sensing: The power of cooperation in the world of Pseudomonas Environ. Microbiol. 7 2005 459 471
156. C.K. Stover, X.Q. Pham, A.L. Erwin, S.D. Mizoguchi, P. Warrener, M.J. Hickey, and et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen Nature 406 2000 959 964
157. O.E. Petrova, and K. Sauer A novel signaling network essential for regulating Pseudomonas aeruginosa biofilm development PLoS Pathog. 5 2009 e1000668
158. O.E. Petrova, and K. Sauer The novel two-component regulatory system BfiSR regulates biofilm development by controlling the small RNA rsmZ through CafA J. Bacteriol. 192 2010 5275 5288
159. H. Mikkelsen, M. Sivaneson, and A. Filloux Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa Environ. Microbiol. 13 2011 1666 1681
160. A.L. Goodman, B. Kulasekara, A. Rietsch, D. Boyd, R.S. Smith, and S. Lory A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa Dev. Cell 7 2004 745 754
161. I. Ventre, A.L. Goodman, I. Vallet-Gely, P. Vasseur, C. Soscia, S. Molin, and et al. Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes Proc. Natl. Acad. Sci. U. S. A. 103 2006 171 176
162. A.L. Goodman, M. Merighi, M. Hyodo, I. Ventre, A. Filloux, and S. Lory Direct interaction between sensor kinase proteins mediates acute and chronic disease phenotypes in a bacterial pathogen Genes Dev. 23 2009 249 259
163. J.A. Moscoso, H. Mikkelsen, S. Heeb, P. Williams, and A. Filloux The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling Environ. Microbiol. 13 2011 3128 3138
164. J.A. Moscoso, T. Jaeger, M. Valentini, K. Hui, U. Jenal, and A. Filloux The diguanylate cyclase SadC is a central player in Gac/Rsm-mediated biofilm formation in Pseudomonas aeruginosa J. Bacteriol. 196 2014 4081 4088
165. M.E. Davey, N.C. Caiazza, and G.A. O'Toole Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1 J. Bacteriol. 185 2003 1027 1036
166. S.J. Pamp, and T. Tolker-Nielsen Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa J. Bacteriol. 189 2007 2531 2539
167. L. Yang, K.B. Barken, M.E. Skindersoe, A.B. Christensen, M. Givskov, and T. Tolker-Nielsen Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa Microbiology 153 2007 1318 1328
168. E. Banin, M.L. Vasil, and E.P. Greenberg Iron and Pseudomonas aeruginosa biofilm formation Proc. Natl. Acad. Sci. U. S. A. 102 2005 11076 11081
169. M.C. Walters III, F. Roe, A. Bugnicourt, M.J. Franklin, and P.S. Stewart Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin Antimicrob. Agents Chemother. 47 2003 317 323
170. K.D. Xu, P.S. Stewart, F. Xia, C.T. Huang, and G.A. McFeters Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability Appl. Environ. Microbiol. 64 1998 4035 4039
171. E. Werner, F. Roe, A. Bugnicourt, M.J. Franklin, A. Heydorn, S. Molin, and et al. Stratified growth in Pseudomonas aeruginosa biofilms Appl. Environ. Microbiol. 70 2004 6188 6196
172. S.J. Pamp, M. Gjermansen, H.K. Johansen, and T. Tolker-Nielsen Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes Mol. Microbiol. 68 2008 223 240
173. K.S. Williamson, L.A. Richards, A.C. Perez-Osorio, B. Pitts, K. McInnerney, P.S. Stewart, and et al. Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population J. Bacteriol. 194 2012 2062 2073
174. E. Banin, K.M. Brady, and E.P. Greenberg Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm Appl. Environ. Microbiol. 72 2006 2064 2069
175. W.C. Chiang, S.J. Pamp, M. Nilsson, M. Givskov, and T. Tolker-Nielsen The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms FEMS Immunol. Med. Microbiol. 65 2012 245 256
176. J.A. Haagensen, M. Klausen, R.K. Ernst, S.I. Miller, A. Folkesson, T. Tolker-Nielsen, and et al. Differentiation and distribution of colistin- and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms J. Bacteriol. 189 2007 28 37
177. G. Herrmann, L. Yang, H. Wu, Z. Song, H. Wang, N. Hoiby, and et al. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa J. Infect. Dis. 202 2010 1585 1592
178. K. Lewis Persister cells Annu. Rev. Microbiol. 64 2010 357 372
179. L. Zhang, W.C. Chiang, Q. Gao, M. Givskov, T. Tolker-Nielsen, L. Yang, and et al. The catabolite repression control protein Crc plays a role in the development of antimicrobial-tolerant subpopulations in Pseudomonas aeruginosa biofilms Microbiology 158 2012 3014 3019
180. P.S. Stewart, M.J. Franklin, K.S. Williamson, J.P. Folsom, L. Boegli, and G.A. James Contribution of stress responses to antibiotic tolerance in Pseudomonas aeruginosa biofilms Antimicrob. Agents Chemother. 59 2015 3838 3847
181. D. Nguyen, A. Joshi-Datar, F. Lepine, E. Bauerle, O. Olakanmi, K. Beer, and et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria Science 334 2011 982 986
182. M. Khakimova, H.G. Ahlgren, J.J. Harrison, A.M. English, and D. Nguyen The stringent response controls catalases in Pseudomonas aeruginosa and is required for hydrogen peroxide and antibiotic tolerance J. Bacteriol. 195 2013 2011 2020
183. M.A. Kohanski, D.J. Dwyer, B. Hayete, C.A. Lawrence, and J.J. Collins A common mechanism of cellular death induced by bactericidal antibiotics Cell 130 2007 797 810
184. D.J. Dwyer, M.A. Kohanski, and J.J. Collins Role of reactive oxygen species in antibiotic action and resistance Curr. Opin. Microbiol. 12 2009 482 489
185. Y. Liu, and J.A. Imlay Cell death from antibiotics without the involvement of reactive oxygen species Science 339 2013 1210 1213
186. I. Keren, Y. Wu, J. Inocencio, L.R. Mulcahy, and K. Lewis Killing by bactericidal antibiotics does not depend on reactive oxygen species Science 339 2013 1213 1216
187. B.S. Tseng, W. Zhang, J.J. Harrison, T.P. Quach, J.L. Song, J. Penterman, and et al. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin Environ. Microbiol. 15 2013 2865 2878
188. N. Bagge, M. Hentzer, J.B. Andersen, O. Ciofu, M. Givskov, and N. Hoiby Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms Antimicrob. Agents Chemother. 48 2004 1168 1174
189. L.R. Hoffman, D.A. D'Argenio, M.J. MacCoss, Z. Zhang, R.A. Jones, and S.I. Miller Aminoglycoside antibiotics induce bacterial biofilm formation Nature 436 2005 1171 1175
190. K.N. Kindrachuk, L. Fernandez, M. Bains, and R.E. Hancock Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 55 2011 1874 1882
191. H. Mulcahy, L. Charron-Mazenod, and S. Lewenza Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms PLoS Pathog. 4 2008 e1000213
192. N. Billings, M. Millan, M. Caldara, R. Rusconi, Y. Tarasova, R. Stocker, and et al. The extracellular matrix component Psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilms PLoS Pathog. 9 2013 e1003526
193. T.F. Mah, B. Pitts, B. Pellock, G.C. Walker, P.S. Stewart, and G.A. O'Toole A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance Nature 426 2003 306 310
194. M. Hentzer, L. Eberl, and M. Givskov Transcriptome analysis of Pseudomonas aeruginosa biofilm development: Anaerobic respiration and iron limitation Biofilms 2 2005 37 61
195. I. Sadovskaya, E. Vinogradov, J. Li, A. Hachani, K. Kowalska, and A. Filloux High-level antibiotic resistance in Pseudomonas aeruginosa biofilm: The ndvB gene is involved in the production of highly glycerol-phosphorylated beta-(1 → 3)-glucans, which bind aminoglycosides Glycobiology 20 2010 895 904
196. L. Zhang, and T.F. Mah Involvement of a novel efflux system in biofilm-specific resistance to antibiotics J. Bacteriol. 190 2008 4447 4452
197. A.J. Jesaitis, M.J. Franklin, D. Berglund, M. Sasaki, C.I. Lord, J.B. Bleazard, and et al. Compromised host defense on Pseudomonas aeruginosa biofilms: Characterization of neutrophil and biofilm interactions J. Immunol. 171 2003 4329 4339
198. M. Alhede, T. Bjarnsholt, P.O. Jensen, R.K. Phipps, C. Moser, L. Christophersen, and et al. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes Microbiology 155 2009 3500 3508
199. E. Mahenthiralingam, M.E. Campbell, and D.P. Speert Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis Infect. Immun. 62 1994 596 605
200. E. Mahenthiralingam, and D.P. Speert Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum Infect. Immun. 63 1995 4519 4523
201. E. Amiel, R.R. Lovewell, G.A. O'Toole, D.A. Hogan, and B. Berwin Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression Infect. Immun. 78 2010 2937 2945
202. V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D.S. Weiss, and et al. Neutrophil extracellular traps kill bacteria Science 303 2004 1532 1535
203. R. Manzenreiter, F. Kienberger, V. Marcos, K. Schilcher, W.D. Krautgartner, A. Obermayer, and et al. Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy J. Cyst. Fibros. 11 2012 84 92
204. M. Dwyer, Q. Shan, S. D'Ortona, R. Maurer, R. Mitchell, H. Olesen, and et al. Cystic fibrosis sputum DNA has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor J. Innate Immun. 6 2014 765 779
205. R.L. Young, K.C. Malcolm, J.E. Kret, S.M. Caceres, K.R. Poch, D.P. Nichols, and et al. Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: Evidence of acquired resistance within the CF airway, independent of CFTR PLoS One 6 2011 e23637
206. P.O. Schiotz, H. Sorensen, and M. Hoiby Activated complement in the sputum from patients with cystic fibrosis Acta Pathol. Microbiol. Scand. C Immunol. 87C 1979 1 5
207. J.N. Jacobsen, A.S. Andersen, M.K. Sonnested, I. Laursen, B. Jorgensen, and K.A. Krogfelt Investigating the humoral immune response in chronic venous leg ulcer patients colonised with Pseudomonas aeruginosa Int. Wound J. 8 2011 33 43
208. J. Davies, O. Neth, E. Alton, N. Klein, and M. Turner Differential binding of mannose-binding lectin to respiratory pathogens in cystic fibrosis Lancet 355 2000 1885 1886
209. R.M. Tan, Z. Kuang, Y. Hao, F. Lee, T. Lee, R.J. Lee, and et al. Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A Infect. Immun. 83 2015 1339 1346
210. M.F. Tosi, H. Zakem, and M. Berger Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch J. Clin. Invest. 86 1990 300 308
211. A. Kharazmi Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa Immunol. Lett. 30 1991 201 205
212. R.E. Hancock, L.M. Mutharia, L. Chan, R.P. Darveau, D.P. Speert, and G.B. Pier Pseudomonas aeruginosa isolates from patients with cystic fibrosis: A class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains Infect. Immun. 42 1983 170 177
213. G.B. Pier, and P. Ames Mediation of the killing of rough, mucoid isolates of Pseudomonas aeruginosa from patients with cystic fibrosis by the alternative pathway of complement J. Infect. Dis. 150 1984 223 228
214. G.B. Pier, F. Coleman, M. Grout, M. Franklin, and D.E. Ohman Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis Infect. Immun. 69 2001 1895 1901
215. E.T. Jensen, A. Kharazmi, P. Garred, G. Kronborg, A. Fomsgaard, T.E. Mollnes, and et al. Complement activation by Pseudomonas aeruginosa biofilms Microb. Pathog. 15 1993 377 388
216. D.B. Learn, E.P. Brestel, and S. Seetharama Hypochlorite scavenging by Pseudomonas aeruginosa alginate Infect. Immun. 55 1987 1813 1818
217. M. Mishra, M.S. Byrd, S. Sergeant, A.K. Azad, M.R. Parsek, L. McPhail, and et al. Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization Cell. Microbiol. 14 2012 95 106
218. A. Holm, and E. Vikstrom Quorum sensing communication between bacteria and human cells: Signals, targets, and functions Front. Plant Sci. 5 2014 309
219. D. Hartl, A. Gaggar, E. Bruscia, A. Hector, V. Marcos, A. Jung, and et al. Innate immunity in cystic fibrosis lung disease J. Cyst. Fibros. 11 2012 363 382
220. A. Manago, K.A. Becker, A. Carpinteiro, B. Wilker, M. Soddemann, A.P. Seitz, and et al. Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase Antioxid. Redox Signal. 22 2015 1097 1110
221. B. Rada, M.A. Jendrysik, L. Pang, C.P. Hayes, D.G. Yoo, J.J. Park, and et al. Pyocyanin-enhanced neutrophil extracellular trap formation requires the NADPH oxidase PLoS One 8 2013 e54205
222. B. Rada, and T.L. Leto Pyocyanin effects on respiratory epithelium: Relevance in Pseudomonas aeruginosa airway infections Trends Microbiol. 21 2013 73 81
223. S.M. Bianchi, L.R. Prince, K. McPhillips, L. Allen, H.M. Marriott, G.W. Taylor, and et al. Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa Am. J. Respir. Crit. Care Med. 177 2008 35 43
224. G. Navarro, A.T. Cheng, K.C. Peach, W.M. Bray, V.S. Bernan, F.H. Yildiz, and et al. Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 58 2014 1092 1099
225. M. Musken, S. Di Fiore, A. Dotsch, R. Fischer, and S. Haussler Genetic determinants of Pseudomonas aeruginosa biofilm establishment Microbiology 156 2010 431 441
226. R.M. Landry, D. An, J.T. Hupp, P.K. Singh, and M.R. Parsek Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance Mol. Microbiol. 59 2006 142 151
227. H. Matsui, V.E. Wagner, D.B. Hill, U.E. Schwab, T.D. Rogers, B. Button, and et al. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms Proc. Natl. Acad. Sci. U. S. A. 103 2006 18131 18136
228. D.D. Sriramulu, H. Lunsdorf, J.S. Lam, and U. Romling Microcolony formation: A novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung J. Med. Microbiol. 54 2005 667 676
229. K.L. Palmer, L.M. Aye, and M. Whiteley Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum J. Bacteriol. 189 2007 8079 8087
230. S.J. Cole, A.R. Records, M.W. Orr, S.B. Linden, and V.T. Lee Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms Infect. Immun. 82 2014 2048 2058
231. B.J. Staudinger, J.F. Muller, S. Halldorsson, B. Boles, A. Angermeyer, D. Nguyen, and et al. Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection Am. J. Respir. Crit. Care Med. 189 2014 812 824
232. T. Bjarnsholt, M. Alhede, M. Alhede, S.R. Eickhardt-Sorensen, C. Moser, M. Kuhl, and et al. The in vivo biofilm Trends Microbiol. 21 2013 466 474
233. N. Hoiby, T. Bjarnsholt, M. Givskov, S. Molin, and O. Ciofu Antibiotic resistance of bacterial biofilms Int. J. Antimicrob. Agents 35 2010 322 332
234. B. Lee, J.A. Haagensen, O. Ciofu, J.B. Andersen, N. Hoiby, and S. Molin Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis J. Clin. Microbiol. 43 2005 5247 5255
235. T. Tolker-Nielsen Pseudomonas aeruginosa biofilm infections: From molecular biofilm biology to new treatment possibilities APMIS Suppl. 138 2014 1 51
236. H. Beyenal, and J. Babauta Microsensors and microscale gradients in biofilms Adv. Biochem. Eng. Biotechnol. 146 2014 235 256
237. M. Skolimowski, M.W. Nielsen, J. Emneus, S. Molin, R. Taboryski, C. Sternberg, and et al. Microfluidic dissolved oxygen gradient generator biochip as a useful tool in bacterial biofilm studies Lab Chip 10 2010 2162 2169
238. M. Skolimowski, M. Weiss Nielsen, F. Abeille, P. Skafte-Pedersen, D. Sabourin, A. Fercher, and et al. Modular microfluidic system as a model of cystic fibrosis airways Biomicrofluidics 6 2012 34109